Toggle Main Menu Toggle Search

Open Access padlockePrints

Prevention of relapse in residual depression by cognitive therapy - A controlled trial

Lookup NU author(s): Dr Peter Cornwall

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Background: Previous studies indicate that depressed patients with partial remission and residual symptoms following antidepressant treatment are common and have high rates of relapse. There is evidence that cognitive therapy may reduce relapse rates in depression. Methods: One hundred fifty-eight patients with recent major depression, partially remitted with antidepressant treatment (mean daily doses equivalent to 185 mg of amitriptyline or 33 mg of fluoxetine) but with residual symptoms of 2 to 18 months' duration, were included in a controlled trial. Subjects were randomized to receive clinical management alone or clinical management plus cognitive therapy for 16 sessions during 20 weeks, with 2 subsequent booster sessions. Subjects were assessed regularly throughout the 20 weeks' treatment and for a further year. They received continuation and maintenance antidepressants at the same dose throughout. Results: Cognitive therapy reduced relapse rates for acute major depression and persistent severe residual symptoms, in both intention to treat and treated per protocol samples. The cumulative relapse rate at 68 weeks was reduced significantly, from 47% in the clinical management control group to 29% with cognitive therapy (hazard ratio 0.54; 95% confidence interval, 0.32-0.93; intention to treat analysis). Cognitive therapy also increased full remission rates at 20 weeks but did not significantly improve symptom ratings. Conclusion: In this difficult-to-treat group of patients with residual depression who showed only partial response despite antidepressant treatment, cognitive therapy produced worthwhile benefit.


Publication metadata

Author(s): Cornwall PL; Paykel ES; Scott J; Teasdale JD; Johnson AL; Garland A; Moore R; Jenaway A; Hayhurst H; Abbott R; Pope M

Publication type: Article

Publication status: Published

Journal: Archives of General Psychiatry

Year: 1999

Volume: 56

Issue: 9

Pages: 829-835

Print publication date: 01/09/1999

ISSN (print): 0003-990X

ISSN (electronic): 1538-3636

Publisher: American Medical Association

URL: http://dx.doi.org/10.1001/archpsyc.56.9.829

DOI: 10.1001/archpsyc.56.9.829


Altmetrics

Altmetrics provided by Altmetric


Share